Partner in
medical innovation

RCTs is an international full-service CRO located in Lyon (France)

For over 30 years, we have been supporting pharmaceutical firms and medical device companies as well as academic sponsors in their research projects.

Linkedin Twitter Contact

Our areas of expertise

The expertise of our teams covers all therapeutic areas and all types of studies (either interventional and non-interventional)

Pre-Authorization Studies

Post-authorization studies on primary data

Secondary Data Studies

Health economics

Health Products (drugs/ DM / IVD MD )

ATU / RTU

Success Stories

Large-scale international phase III study

Study requested by the Authorities

Assessment of the impact of the delisting of a therapeutic class in France: the AASAL case

Cost-benefit analysis on early vs. late knee prosthesis in French patients with gonarthrosis

Early access and real word data: the example of the DARATUMUMAB cohort ATU

CE marking of DBLG1 ™, the innovative technological solution that integrates artificial intelligence

They trust us

We take care of your projects from AZ

From the study design to the drafting of the clinical report, including monitoring and statistical analysis, RCTs can support you in all stages of your project development.

* Randomized controlled trials are among the Gold Standard methods of medical analysis. Transparent, efficient and objective, are the qualities that led to the creation of RCTs.

Find out about us

News

Cardiovasculaire

Rivaroxaban or Enoxaparin in Nonmajor Orthopedic Surgery

Utilisation quotidienne du facteur VII activé recombinant dans les saignements aigus de l’hémophile acquise A : résultats d’ACQUI-7, une étude française prospective

Interview with Alain Baleydier at the 2020 Clinical Research Day

Success stories

Large-scale international phase III study

Success stories

Study requested by the Authorities

Success stories

Assessment of the impact of the delisting of a therapeutic class in France: the AASAL case

Success stories

Cost-benefit analysis on early vs. late knee prosthesis in French patients with gonarthrosis

Success stories

Early access and real word data: the example of the DARATUMUMAB cohort ATU

Success stories

CE marking of DBLG1 ™, the innovative technological solution that integrates artificial intelligence

Happy new year 2020!

#RiskBasedMonitoring by Morgane Champiot

AFCROs morning #SNDS data chaining

Audrey Lajoinie's feedback on the probabilistic pairing of a national register with the SNDS

Daily consumption of pistachios over 12 weeks improves dietary profile without increasing body weight in healthy women

Transplantation

A Prospective, Observational Study of Conversion From Immediate- to Prolonged-Release Tacrolimus in Renal Transplant Recipients in France: The OPALE Study

Our tailored digital solutions

Your international studies